| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.39B | 1.32B | 1.26B | 1.30B | 1.20B |
| Gross Profit | 537.38M | 482.95M | 441.07M | 437.73M | 432.73M |
| EBITDA | 198.39M | 181.43M | 141.71M | 118.18M | 155.45M |
| Net Income | 116.10M | 86.95M | 44.52M | 19.56M | 55.23M |
Balance Sheet | |||||
| Total Assets | 1.77B | 1.17B | 1.23B | 1.27B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 71.32M | 99.23M | 110.50M | 97.56M | 97.25M |
| Total Debt | 264.53M | 383.14M | 515.45M | 610.62M | 615.59M |
| Total Liabilities | 565.85M | 681.67M | 804.15M | 904.97M | 966.66M |
| Stockholders Equity | 1.21B | 489.15M | 425.95M | 361.54M | 363.40M |
Cash Flow | |||||
| Free Cash Flow | 121.71M | 114.64M | 115.93M | 24.62M | 58.62M |
| Operating Cash Flow | 167.91M | 148.43M | 142.03M | 43.06M | 86.69M |
| Investing Cash Flow | -46.19M | -30.37M | -19.51M | -18.44M | -28.07M |
| Financing Cash Flow | -159.29M | -125.23M | -111.56M | -19.49M | -60.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $1.68B | 14.41 | 20.55% | 0.21% | 5.11% | 34.02% | |
65 Neutral | $1.45B | 18.08 | 8.11% | 2.39% | 1.78% | -25.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $1.36B | 11.21 | -1.95% | 4.16% | 4.34% | -141.36% | |
57 Neutral | $1.53B | 6.47 | 27.51% | 1.84% | -6.03% | ― | |
54 Neutral | $145.28M | -1.14 | -11.27% | 7.20% | -12.09% | -204.66% | |
53 Neutral | $1.25B | 53.13 | 6.19% | ― | 1.77% | -44.11% |
Interface reported record fourth-quarter and full-year 2025 results on February 24, 2026, with net sales rising 4.3% in the quarter to $349 million and 5.4% for the year to $1.39 billion, and GAAP earnings per diluted share reaching $0.41 for the quarter and $1.96 for 2025. Profitability improved as gross margin expanded to 38.7% for the year, adjusted EPS grew 33% to $1.94, and strong cash generation enabled $128 million of debt repayment, extended maturities to 2030, higher dividends and $13 million of share repurchases, underscoring the momentum of its One Interface strategy and market share gains in key sectors.
Management highlighted broad-based growth across regions and product categories, with especially strong 2025 billings in healthcare and education and continued share gains in corporate office. Executives emphasized that operational discipline, favorable pricing and mix, manufacturing efficiencies and disciplined capital allocation have strengthened the balance sheet and reinforced the company’s positioning as a design and sustainability leader despite ongoing macroeconomic uncertainty.
The most recent analyst rating on (TILE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on Interface stock, see the TILE Stock Forecast page.
Interface, Inc. entered into a Third Amended and Restated Syndicated Facility Agreement on December 3, 2025, with its foreign subsidiaries as co-borrowers and domestic subsidiaries as guarantors, alongside Bank of America and other lenders. The agreement introduces changes such as amended interest rates, an extended maturity date to December 3, 2030, a new $170 million term loan facility, and a reduced revolving credit facility. Additionally, Interface redeemed its $300 million Senior Notes due 2028 using proceeds from the term loan and cash on hand, effectively terminating obligations under the previous Indenture.
The most recent analyst rating on (TILE) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Interface stock, see the TILE Stock Forecast page.